ResearchMoz.us include new market research report " China Animal Vaccine Industry Report, 2013-2016: Market Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.
Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main force of traditional animal vaccine markets in the world, still taking around 60% nowadays.
View Full Report with TOC at: http://www.researchmoz.us/china-animal-vaccine-industry-report-2013-2016-report.html
In recent years, European and American animal vaccine markets have decelerated growth due to quality safety, high maturity and other factors, while the fast-growing animal vaccine market of China and other emerging countries will become a new highlight.
In 2004-2013, Chinese animal vaccine market size maintained a high growth rate of 26.3%, reaching about RMB11.5 billion in 2013. The growth in 2007-2010 was mainly driven by the expansion of governmental tender vaccine, while that from 2011 was primarily thanks to the market-oriented vaccine expansion. The Chinese animal vaccine market is basically occupied by local companies, showing a self-sufficiency rate of around 90%.
Given the policy factor, Chinese animal vaccine products are divided into compulsory immunization vaccines and market-oriented vaccines. At present, the former include foot-and-mouth disease (FMD), bird flu, porcine reproductive and respiratory syndrome (PRRS), swine fever, and peste des petits ruminants (PPR); the latter refer to porcine circovirus (PCV), Newcastle disease, porcine parvovirus (PPV) and other varieties. Since 2011, the bids for compulsory vaccines proposed by the Chinese government has turned to be more fierce, with limited growth potential; however, market-oriented vaccines have developed faster, enjoying 40%-50% market share in 2013.
Browse More Reports related to Biotechnology at: http://www.researchmoz.us/biotechnology-market-reports-30.html
In 2006, China implemented mandatory veterinary drug GMP certification to raise the threshold, resulting in a sharp decline in the number of animal vaccine companies and the accompanying increased industry concentration. In 2013, CAHIC seized the highest market share of 10.5% among Chinese listed animal vaccine companies, followed by Jinyu Group, Tecon and Dahuanong with a combined proportion of 15% or so.
About Us:
ResearchMoz ( http://www.researchmoz.us/ ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
For More Information Kindly Contact:
Mrs.Sheela AK
Tel:+1-518-618-1030
Toll Free: 866-997-4948
Email: sales@researchmoz.us
0 comments:
Post a Comment